Table 3.

Multivariate Logistic Regression: Compliance 6 Months after Switching

	OR (95 % CI)	p value
10-year increase in age	1.13 (1.07, 1.19)	< 0.001
Race/ethnicity
NHW (ref)	1.00
African American	0.88 (0.63, 1.22)	0.448
Hispanic	0.68 (0.52, 0.91)	0.009
Asian	0.92 (0.61, 1.37)	0.681
Other†	0.88 (0.70, 1.09)	0.227
Unknown	0.96 (0.81, 1.14)	0.643
Unit increase in statin potency level at switch	0.87 (0.80, 0.94)	0.001
Potency change at switch
Less potent (ref)	1.00
Equipotent	1.41 (1.16, 1.70)	< 0.001
More potent	1.15 (0.84, 1.56)	0.373
Brand statin compliance	4.68 (4.07, 5.39)	< 0.001
Statin supply at switch
30 days (ref)	1.00
90 days	2.10 (1.76, 2.49)	< 0.001
Miscellaneous	0.89 (0.52, 1.51)	0.658
60-day increase in brand statin treatment	1.01 (1.00, 1.02)	0.001
60-day increase in generic statin treatment	0.51 (0.42, 0.60)	< 0.001
Pearson’s chi-square test, p = 0.310

NHW non-Hispanic white

† Pacific Islander, Asian Indian, Native Alaskan, or reported as multiple races or “other”